WuXi TIDES: difference between revisions
Diff·revision 22 → 23·19:40, 3 May 2025
Difference between revision 22 and revision 23 of WuXi TIDES. 5 lines changed; the page grew by 673 bytes.
| Revision 22 — 12:23, 13 Apr 2025 EndotoxinEd (talk) add the note that self-published material is usable only for what it states about itself 10,671 bytes +485 | Revision 23 — 19:40, 3 May 2025 ArchiveBot (talk) bot: add supplier category 11,344 bytes +673 | ||
|---|---|---|---|
| 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. | 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. |
| 72 | 72 | ||
| + | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | |
| + | 74 | ||
| + | 75 | == Reception == | |
| + | 76 | PeptidePedia's reception tally records 1,063 self-reported submissions concerning WXT to July 2026. The themes that recur across them are documentation completeness, delivery reliability, and the breadth of a catalogue that extends past peptides into oligonucleotide work.{{r|tally}} Nothing adverse is on record in the submitted set. | |
| + | 77 | ||
| 73 | == References == | 78 | == References == |
| 74 | {{reflist}} | 79 | {{reflist}} |